We're Moving to Revvity.com
Visitors from the United States and Canada can now explore, discover, and buy our products and services at Revvity.com. You will be automatically redirected to Revvity.com
Not located in the United States or Canada?
We're Moving to Revvity.com
Visitors from the United States and Canada can now explore, discover, and buy our products and services at Revvity.com. You will be automatically redirected to Revvity.com
Not located in the United States or Canada?
Renin is a peptide hormone secreted by the kidney from granular cells of the juxtaglomerular apparatus. This secretion is the first step in a cascade of events that leads to increased blood pressure. Renin is upregulated in response to sympathetic nervous system activity, a decrease in arterial blood pressure, or a decrease in plasma sodium chloride levels. Specifically, renin upregulation leads to increased blood pressure by cleaving angiotensinogen (produced in the liver) to yield angiotensin I, which is further converted to angiotensin II. Angiotensin II constricts blood vessels, increases aldosterone secretion from the adrenals, and stimulates a thirst reflex.
ReninSense™ 680 FAST is a renin activatable agent that is optically silent upon injection and produces fluorescent signal after cleavage by renin produced in the kidneys. The Renin-Angiotensin System (RAS) is the hormone system involved in regulating blood pressure and fluid balance in the body. ReninSense 680 FAST may be used to monitor abnormal RAS function, progression of disease, and the efficacy of therapeutic treatment in disorders such as hypertension and cardiovascular disease and some neurological diseases. Specifically, ReninSense 680 FAST is recognized and activated by rodent forms of renin in preclinical animal models.
ReninSense 680 FAST is a member of a family of the activatable fluorescent imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology). These agents confer an improved pharmacokinetic profile with a broader range of early imaging time points. This architecture also offers higher target specific signal with reduced background.
Product | Catalog Number | Ex/Em wavelength (nm) | Molecular weight (g/mol) | Validated Experiments | Applications | Storage and Stability |
ReninSense 680 FAST | NEV11079 | 675/693 | 43,000 | In vivo/Ex vivo Flow cytometry In vitro microscopy | Oncology Renal Hypertension Neurological diseases | Technical Data Sheet |
The recommended procedure for in vivo imaging with ReninSense 680 FAST is administration via intravenous injection and imaging 24 hours post injection. Earlier and later time points may be appropriate for some disease models, and the optimal imaging time point for any application should be determined empirically.
View a more-complete imaging protocol.
Product | Route of Injection | Mouse Dose (25 g) | Rat Dose (250 g) | Blood t 1/2 | Tissue t 1/2 | Optimal imaging time | Optimal Re-injection Time (complete clearance) | Route of Metabolism/ background tissue | FMT and IVIS settings |
ReninSense 680 FAST | IV | 2 nmol | 6-20 nmol | 7 h | 48 h
| 24 (12-24) h
| 4 d | Kidney, lung, liver | FMT 680/700
IVIS 675/720 |
We have validated ReninSense 680 FAST for use with frozen tissue samples (kidney tissue). Here is a brief protocol with a recommended concentration of agent to use:
A. No, ReninSense 680 FAST is intended for animal research only and not for use in humans.
A. The blood can be drawn however you are comfortable. Our experts do not recommend storing the samples because it can affect the fluorescent signal.
Please visit our Citations Library for references using ReninSense 680 FAST on the IVIS or on the FMT.